The mechanism of drug resistance is that it rapidly inactivates BACH1, enabling NRF2‐regulated cytoprotective and detoxification genes to be induced rapidly, thus preventing AML cells from bortezomib‐mediated apoptosis.[449] BACH1 plays a beneficial role in MM as well. Here, BACH1 is linked to acute myeloid leukemia.